The earnings scorecard for the week was decked in green, with 51 S&P 500 companies reporting EPS wins out of the 77 that ...
Novartis exceeds Q4 2024 expectations with 16% sales growth, strong EPS trajectory, and strategic R&D investments. Read why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results